BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28268254)

  • 1. Plasma Epstein-Barr virus DNA for pediatric Burkitt lymphoma diagnosis, prognosis and response assessment in Malawi.
    Westmoreland KD; Montgomery ND; Stanley CC; El-Mallawany NK; Wasswa P; van der Gronde T; Mtete I; Butia M; Itimu S; Chasela M; Mtunda M; Kampani C; Liomba NG; Tomoka T; Dhungel BM; Sanders MK; Krysiak R; Kazembe P; Dittmer DP; Fedoriw Y; Gopal S
    Int J Cancer; 2017 Jun; 140(11):2509-2516. PubMed ID: 28268254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hodgkin lymphoma, HIV, and Epstein-Barr virus in Malawi: Longitudinal results from the Kamuzu Central Hospital Lymphoma study.
    Westmoreland KD; Stanley CC; Montgomery ND; Kaimila B; Kasonkanji E; El-Mallawany NK; Wasswa P; Mtete I; Butia M; Itimu S; Chasela M; Mtunda M; Chikasema M; Makwakwa V; Kampani C; Dhungel BM; Sanders MK; Krysiak R; Tomoka T; Liomba NG; Dittmer DP; Fedoriw Y; Gopal S
    Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27781380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoma and Epstein-Barr virus DNA in blood during interleukin-2 therapy in antiretroviral-naïve HIV-1-infected patients: a substudy of the ANRS 119 trial.
    de Lastours V; LeGoff J; Brière J; Agbalika F; Boulet T; Lévy Y; Simon F; Aboulker JP; Molina JM
    HIV Med; 2014 Jan; 15(1):23-9. PubMed ID: 24007426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic Changes of Post-Radiotherapy Plasma Epstein-Barr Virus DNA in a Randomized Trial of Adjuvant Chemotherapy Versus Observation in Nasopharyngeal Cancer.
    Hui EP; Ma BBY; Lam WKJ; Chan KCA; Mo F; Ai QH; King AD; Wong CH; Wong KCW; Lam DCM; Tong M; Poon DMC; Li L; Lau TKH; Wong KH; Lo YMD; Chan ATC
    Clin Cancer Res; 2021 May; 27(10):2827-2836. PubMed ID: 33692028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High pretreatment plasma Epstein-Barr virus (EBV) DNA level is a poor prognostic marker in HIV-associated, EBV-negative diffuse large B-cell lymphoma in Malawi.
    Montgomery ND; Randall C; Painschab M; Seguin R; Kaimila B; Kasonkanji E; Zuze T; Krysiak R; Sanders MK; Elliott A; Miller MB; Kampani C; Chimzimu F; Mulenga M; Damania B; Tomoka T; Fedoriw Y; Dittmer DP; Gopal S
    Cancer Med; 2020 Jan; 9(2):552-561. PubMed ID: 31782984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective evaluation of plasma Epstein-Barr virus DNA clearance and fluorodeoxyglucose positron emission scan in assessing early response to chemotherapy in patients with advanced or recurrent nasopharyngeal carcinoma.
    Ma B; Hui EP; King A; Leung SF; Kam MK; Mo F; Li L; Wang K; Loong H; Wong A; Chan CM; Chan KCA; Wong SCC; Lo YMD; Chan AT
    Br J Cancer; 2018 Apr; 118(8):1051-1055. PubMed ID: 29555989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Epstein-Barr Viral Deoxyribonucleic Acid Predicts Worse Outcomes in Pediatric Nonmetastatic Nasopharyngeal Carcinoma Patients: An Observational Study of 89 Cases in an Endemic Area.
    Shen T; Tang LQ; Gu WG; Luo DH; Chen QY; Li PJ; Mai DM; Mai HQ; Mo HY
    Medicine (Baltimore); 2015 Dec; 94(50):e1945. PubMed ID: 26683909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Epstein Barr virus (EBV) DNA as a biomarker for EBV associated Hodgkin lymphoma.
    Dinand V; Sachdeva A; Datta S; Bhalla S; Kalra M; Wattal C; Radhakrishnan N
    Indian Pediatr; 2015 Aug; 52(8):681-5. PubMed ID: 26388626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term survival analysis of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA levels.
    Wang WY; Twu CW; Chen HH; Jiang RS; Wu CT; Liang KL; Shih YT; Chen CC; Lin PJ; Liu YC; Lin JC
    Cancer; 2013 Mar; 119(5):963-70. PubMed ID: 23065693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent traces of EBV infection in Hodgkin and non-Hodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomas.
    Mundo L; Del Porro L; Granai M; Siciliano MC; Mancini V; Santi R; Marcar L; Vrzalikova K; Vergoni F; Di Stefano G; Schiavoni G; Segreto G; Onyango N; Nyagol JA; Amato T; Bellan C; Anagnostopoulos I; Falini B; Leoncini L; Tiacci E; Lazzi S
    Mod Pathol; 2020 Dec; 33(12):2407-2421. PubMed ID: 32483241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term clinical outcome in nasopharyngeal carcinoma patients with post-radiation persistently detectable plasma EBV DNA.
    Wang WY; Lin TY; Twu CW; Tsou HH; Lin PJ; Liu YC; Huang JW; Hsieh HY; Lin JC
    Oncotarget; 2016 Jul; 7(27):42608-42616. PubMed ID: 27191654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus biomarkers have no prognostic value in HIV-related Hodgkin lymphoma in the modern combined antiretroviral therapy era.
    Lupo J; Germi R; Lancar R; Algarte-Genin M; Hendel-Chavez H; Taoufik Y; Mounier N; Partisani M; Bonnet F; Meyohas MC; Marchou B; Semanova T; Prevot S; Costagliola D; Morand P; Besson C
    AIDS; 2019 May; 33(6):993-1000. PubMed ID: 30946153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features.
    Richter J; John K; Staiger AM; Rosenwald A; Kurz K; Michgehl U; Ott G; Franzenburg S; Kohler C; Finger J; Oschlies I; Paul U; Siebert R; Spang R; Burkhardt B; Klapper W
    Br J Haematol; 2022 Feb; 196(3):681-689. PubMed ID: 34617271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus from Burkitt Lymphoma biopsies from Africa and South America share novel LMP-1 promoter and gene variations.
    Lei H; Li T; Li B; Tsai S; Biggar RJ; Nkrumah F; Neequaye J; Gutierrez M; Epelman S; Mbulaiteye SM; Bhatia K; Lo SC
    Sci Rep; 2015 Nov; 5():16706. PubMed ID: 26593963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr Virus Genomes Reveal Population Structure and Type 1 Association with Endemic Burkitt Lymphoma.
    Kaymaz Y; Oduor CI; Aydemir O; Luftig MA; Otieno JA; Ong'echa JM; Bailey JA; Moormann AM
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32581102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early stage of Epstein-Barr virus lytic infection leading to the "starry sky" pattern formation in endemic Burkitt lymphoma.
    Fujita S; Buziba N; Kumatori A; Senba M; Yamaguchi A; Toriyama K
    Arch Pathol Lab Med; 2004 May; 128(5):549-52. PubMed ID: 15086279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sequential monitoring of plasma EBV-DNA level in a patient with EBV-positive Hodgkin lymphoma].
    Uchida E; Honma R; Igarashi A; Kurata M; Imadome K; Omoto E; Miura O; Arai A
    Rinsho Ketsueki; 2012 Jan; 53(1):87-91. PubMed ID: 22374530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma.
    Grande BM; Gerhard DS; Jiang A; Griner NB; Abramson JS; Alexander TB; Allen H; Ayers LW; Bethony JM; Bhatia K; Bowen J; Casper C; Choi JK; Culibrk L; Davidsen TM; Dyer MA; Gastier-Foster JM; Gesuwan P; Greiner TC; Gross TG; Hanf B; Harris NL; He Y; Irvin JD; Jaffe ES; Jones SJM; Kerchan P; Knoetze N; Leal FE; Lichtenberg TM; Ma Y; Martin JP; Martin MR; Mbulaiteye SM; Mullighan CG; Mungall AJ; Namirembe C; Novik K; Noy A; Ogwang MD; Omoding A; Orem J; Reynolds SJ; Rushton CK; Sandlund JT; Schmitz R; Taylor C; Wilson WH; Wright GW; Zhao EY; Marra MA; Morin RD; Staudt LM
    Blood; 2019 Mar; 133(12):1313-1324. PubMed ID: 30617194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Role of the Expression of Latent-Membrane Protein 1 of Epstein-Barr Virus in Classical Hodgkin Lymphoma.
    Santisteban-Espejo A; Perez-Requena J; Atienza-Cuevas L; Moran-Sanchez J; Fernandez-Valle MDC; Bernal-Florindo I; Romero-Garcia R; Garcia-Rojo M
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clearance of circulating Epstein-Barr virus DNA in children with acute malaria after antimalaria treatment.
    Donati D; Espmark E; Kironde F; Mbidde EK; Kamya M; Lundkvist A; Wahlgren M; Bejarano MT; Falk KI
    J Infect Dis; 2006 Apr; 193(7):971-7. PubMed ID: 16518759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.